Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$11.34 and traded as low as C$11.27. Fennec Pharmaceuticals shares last traded at C$11.27, with a volume of 100 shares trading hands. Fennec Pharmaceuticals Price […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the business’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total value of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total transaction of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The shares were sold at an average price of $8.47, for a total value of $18,693.29. Following the sale, the director now directly owns 28,826 shares in the company, valued […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) CFO Robert Andrade sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $8.99, for a total value of $89,900.00. Following the transaction, the chief financial officer now directly owns 139,721 shares in the company, […]